Additional Information

Description

Methotrexate 250 mg/10 mL W/P Ea is a sterile, isotonic solution intended for medical use. It is formulated with a preservative to ensure the stability and safety of the solution during storage and handling. This formulation is designed to be used in specific therapeutic contexts, under the guidance of a healthcare provider.

Methotrexate is a chemotherapy agent and an immunosuppressive drug. It works by inhibiting the enzyme dihydrofolate reductase, which is crucial in the synthesis of nucleotides. It is primarily used in the treatment of certain cancers, such as leukemia and lymphoma, as well as autoimmune diseases like rheumatoid arthritis and psoriasis.

It is important to note that this product is not intended for intrathecal use. Intrathecal administration, which involves direct injection into the cerebrospinal fluid, can result in severe toxicity. Healthcare providers must follow appropriate guidelines when choosing the administration route for this medication.